// App-Quantinova.ai

SAT-227 : Comparative Treatment Outcomes In Patients With Prior Fracture Previously Treated With A Bisphosphonate: Results From The Denosumab/Ibandronate and Denosumab/Risedronate Trials

Researchers

Presenter

  • Christian Roux

Principal Investigators

  • Pei-Ran Ho

  • Jesse Hall

  • Henry G Bone

  • Sydney Bonnick

  • Joop van den Bergh

  • Irene Ferreira

  • Rachel B Wagman

  • Jacques P Brown

Medical Centers

  • United Osteoporosis Centers, Gainesville, GA

  • CHU de Quebec and Laval University, Quebec, QC, Canada

  • Clinical Research Center of North Texas, Denton, TX

  • VieCuri Medical Centre and Maastricht University, Venlo, Netherlands

  • Paris Descartes University, Paris, France

  • Michigan Bone and Mineral Clinic, Detroit, MI

Locations

  • United States

  • Canada

  • France

  • Netherlands

Companies

  • Amgen Inc.

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Osteoporosis

Biomarkers

  • Transthyretin

  • Bone Mineral Density

Drug/Treatment

  • Ibandronic acid

  • Risedronate sodium

  • Denosumab

Outcome

  • N/A

Study Design

  • open label

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved